Leaflet GRANISETRON KABI 1mg / ml concentrate for solution for injection / infusion

Product code:
W53853002
Quantity:
10
Indicated for:
chemotherapy-induced nausea and vomiting
Route of administration:
injectable / infusion
Substance:
granisetron (antiemetic)
ATC
A04AA02 — Alimentary tract and metabolism | Antiemetics and antinauseants | Antiemetics and antinauseants | Serotonin (5ht3) antagonists
Granisetron is a medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It belongs to a class of drugs known as 5-HT3 receptor antagonists.

This medication works by blocking the action of serotonin, a natural substance in the body that can trigger nausea and vomiting. It is available in tablet form, transdermal patches, or injectable solutions.

Granisetron is generally well-tolerated but may cause side effects such as headaches, constipation, or dizziness. In rare cases, severe allergic reactions may occur.

It is important to use granisetron as directed by your doctor and to inform medical staff about any other medications you are taking to avoid interactions.

General data about GRANISETRON KABI 1mg / ml

Substance:
granisetron
Date of latest medicines list:
01-04-2014
Product code:
W53853002
Concentration:
1mg / ml
Pharmaceutical form:
concentrate for solution for injection / infusion
Packing volume:
1ml
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
LABESFAL-LABORATORIOS ALMIRO S.A. - PORTUGALIA
Holder:
FRESENIUS KABI ROMANIA S.R.L. - ROMANIA
Number:
5462/2013/02
Shelf life:
3 years-after packing for marketing; after the first opening-it is used immediately

Concentrations available for granisetron

  • 1mg
  • 1mg/1ml
  • 1mg/ml
  • 20mcg/ml
  • 2mg
  • 3.1mg/24h
  • 3mg/3ml